Uterine kallikrein and arterial bradykinin activities and uterine arterial proliferation in response to acute estradiol-17β exposure in ovariectomized ewes

Domest Anim Endocrinol. 2022 Oct:81:106748. doi: 10.1016/j.domaniend.2022.106748. Epub 2022 Jun 11.

Abstract

Estradiol-17β (E2) increases kallikrein in rodent and human reproductive tissues. Kallikrein specific activity is increased in the porcine uterus when conceptus E2 is secreted at maternal recognition of pregnancy. When kallikrein acts on kininogen to liberate bradykinin, angiogenic and vasoactive factors are released. The uterus of ovariectomized ewes administered E2 undergoes rapid vascular changes via different patterns of angiogenic and vasoactive factors. Our hypothesis was that E2 would increase the specific activity and protein secretion of tissue kallikrein in endometrial explants culture media (ECM) and ewes exposed to E2 would have uterine arteries that would be more sensitive to the vasodilatory effects of bradykinin. Ovariectomized ewes received 100 mg of E2 implants for 0, 12, 24, or 48 h. After treatment, uterine weights were determined, and caruncles were processed for ECM. Uterine weights and uterine weight per ewe body weight were significantly greater in the 12 and 24 h ewes compared with the 0 h ewes, with the 48 h ewes being similar to the 24 h ewes. There were no statistically significant differences in caruncular tissue kallikrein protein secretion among the treatment groups. There was a tendency (P = 0.09) for duration of E2 exposure to influence tissue kallikrein specific activity where kallikrein activity was greater (P ≤ 0.05) in the 12 and 48 h ewes compared with the 0 h ewes, with 24 h ewes being intermediate (unprotected F test). Uterine arteries from ewes with E2 for 24 and 48 h had more sensitivity to bradykinin, via the bradykinin receptor 2, than uterine arteries from ewes with 0 or 12 h E2 exposure. We fail to reject our hypothesis as E2 did elicit a positive response in tissue kallikrein specific activity and bradykinin response. Further investigations are needed to determine how kallikrein and bradykinin may be involved in vascular remodeling of the ovine uterus.

Keywords: Arterial function; Bradykinin; Estradiol-17β; Kallikrein; Sheep; Uterus.

MeSH terms

  • Animals
  • Bradykinin* / metabolism
  • Bradykinin* / pharmacology
  • Cell Proliferation
  • Estradiol* / metabolism
  • Estradiol* / pharmacology
  • Female
  • Humans
  • Kallikreins / metabolism
  • Kallikreins / pharmacology
  • Pregnancy
  • Sheep
  • Swine
  • Tissue Kallikreins / metabolism
  • Tissue Kallikreins / pharmacology
  • Transcription Factors / metabolism
  • Uterus / metabolism

Substances

  • Transcription Factors
  • Estradiol
  • Kallikreins
  • Tissue Kallikreins
  • Bradykinin